National Comprehensive Cancer Network



About NCCN

Acute Myeloid Leukemia Panel - Disclosures as of 3/28/2012

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Camille N. Abboud, MD

None

Bristol-Myers Squibb Company;
Genzyme Corporation;
Novartis Pharmaceuticals Corporation

None

None

4/5/2013

Jessica Altman, MD

None

Celgene Corporation;
Epicept

None

None

5/19/2013

Frederick R. Appelbaum, MD

None

None

None

None

3/26/2013

Daniel A. Arber, MD

None

US Diagnostic Standards

None

None

4/29/2013

Eyal Attar, MD

None

None

None

None

2/7/2013

Uma Borate, MD

GlaxoSmithKline

None

None

None

8/24/2012

Steven E. Coutre, MD

None

Celgene Corporation;
Novartis Pharmaceuticals Corporation

None

None

5/16/2013

Lloyd E. Damon, MD

None

None

None

None

2/19/2013

Lauren Gallagher, RPh, PhD

None

None

None

None

6/18/2013

Salil Goorha, MD

None

None

None

None

3/7/2012

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2012

Jeffrey Lancet, MD

None

Celgene Corporation;
Genzyme Corporation

None

None

8/6/2012

Lori J. Maness, MD

Cyclacel, LTD

None

None

None

3/9/2012

Guido Marcucci, MD

None

None

None

None

8/15/2012

Joan S. McClure, MS

None

None

None

None

7/23/2012

Michael M. Millenson, MD, FACP

None

None

None

None

2/22/2013

Joseph O. Moore, MD

ARIAD Pharmaceuticals, Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

Amgen Inc.;
Genentech, Inc.;
Novartis Pharmaceuticals Corporation

None

None

8/24/2012

Maoko Naganuma, MSc

None

None

None

None

2/28/2013

Margaret R. O'Donnell, MD

National Cancer Institute

None

None

None

5/30/2013

Farhad Ravandi, MD

None

Bayer HealthCare;
Cephalon, Inc.;
Eisai Inc.;
Genzyme Corporation;
Novartis Pharmaceuticals Corporation;
Sunesis Pharmaceuticals, Inc.

None

None

11/3/2012

Paul J. Shami, MD

None

Genzyme Corporation;
Novartis Pharmaceuticals Corporation;
Novartis Pharmaceuticals Corporation

None

None

1/28/2013

B. Douglas Smith, MD

None

Novartis Pharmaceuticals Corporation

None

None

1/19/2013

Richard M. Stone, MD

Celgene Corporation;
Novartis Pharmaceuticals Corporation;
Sunesis Pharmaceuticals, Inc.

ARIAD Pharmaceuticals, Inc.;
Celgene Corporation;
Genzyme Corporation

None

None

6/3/2013

Stephen A. Strickland, MD

GlaxoSmithKline;
Novartis Pharmaceuticals Corporation;
Ambit;
Cyclacel Pharmaceuticals;
sanofi-aventis U.S.;
Sunesis Pharmaceuticals, Inc.

Genzyme Corporation

None

None

3/25/2013

Martin S. Tallman, MD

None

Genzyme Corporation

None

None

10/16/2012

Eunice S. Wang, MD

None

None

None

None

8/20/2012

 

About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us

275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved